Molecular Templates to Present at the Upcoming Investor Conferences

2 years ago

AUSTIN, Texas, March 01, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical…

Halberd’s COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

2 years ago

Outperforms Approved COVID AntibodiesJackson Center, Pennsylvania--(Newsfile Corp. - March 1, 2022) - Halberd Corporation's (OTC Pink: HALB) previously developed SARS-CoV-2…

Red Light Holland Reports Fiscal Third Quarter Results

2 years ago

Company announces 28% increase in revenue and 48% increase in gross profit over the previous quarterNine-month revenues of $1,703,122Toronto, Ontario--(Newsfile…

Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial

2 years ago

LANCER Trial expanded to include up to 20 Additional Clinical Research CentersOakville, Ontario--(Newsfile Corp. - March 1, 2022) - Cardiol…

MEDITECH Expanse Ambulatory Now Available to Independent and Physician-Owned Practices

2 years ago

The solution’s web- and touch-based design offers a personalized user experience and efficient office workflows, without requiring an Expanse EHR…

Social Security Administration (SSA) Selects Veradigm eChart Courier™ to Automate Medical Chart Retrieval

2 years ago

Secure web services connection between SSA and Veradigm to reduce patient health record retrieval time from weeks or days to…

Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million

2 years ago

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and…

TriMas Announces Acquisition of Intertech

2 years ago

Further Expands TriMas’ Packaging Group into Medical End Market Applications BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it…

LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY

2 years ago

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser…

CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer

2 years ago

∙ The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and therapeutics  ∙ CureVac RNA Printer…